I gave a short talk today at a WHO symposium on COVID-19 vaccine correlates of immunity. It was an excellent conference. My role was to highlight and discuss potential roles of T cells in vaccine mechanisms or correlates of protection. 🧵
I decided to record a copy of the presentation, posted above.
The conference was organized by Stanley Plotkin
As part of the talk I show this model. The concept here is that as variant divergence increases, the amount of the protective immunity provided by neutralizing antibodies decreases, but the amount of protective immunity provided by memory T cells and B cells is preserved.
The amounts of those immunity contributions at preventing or reducing COVID-19 are open to discussion. And hopefully you can tell from the drawing that this is not a formal model.
Thanks to @nataliexdean for the encouragement to post this. 🙂
The topic of how multiple branches of the immune system are likely valuable for fighting variants is nicely covered in this Scientific American article. (plus it shows an exploded virus!)
Moderna vaccine works in teenagers!
🔵 Immune responses as good as adults
🔵 Same side effects as adults
🔵 Data will go to FDA for approval now
🧵 apnews.com/article/modern…
Overall, the Moderna and Pfizer vaccine results have been virtually identical for protection and immune responses, so these results in teenagers are not a surprise, since the Pfizer vaccine did great in teenagers.
But the Moderna results are still really good to see! Two independent vaccines in parallel getting the same results gives a lot of confidence about the protection!
Vaccination of immunocompromised or immunosuppressed people against COVID is a major topic now.
I think this is good simple advice:
"Get vaccinated, but behave as though you're not," Dorlan Kimbrough, a neurologist who treats multiple sclerosis patients at Duke. 🧵
It is early days for understanding and advice on this, but thankfully there are already scientific studies (preprints) being published on COVID vaccine immune responses in such patients. These are two good new news articles on the topic: advisory.com/en/daily-brief…
“The fact that there is real-world data that shows the Pfizer vaccine works very well against the South African variant, it's quite likely that both the Pfizer and Moderna vaccines will be very effective against these new Indian variants, as well,”
That is based on:
🔵 data from Qatar against B1351 (97% protection against severe disease, 75% against infection)
🔵@SutharLab B1617 neutralizing Ab data
🔵L452R containing CAL.C20 variant antibody data
Overall, this new delayed dose vaccine study it is a high quality study. Bottom lines:
🔵 The UK delayed vaccination is working for them, and allows vaccination of more people. And the new data support that. I am really happy about that!
🔵 But, if you have enough doses, getting the 2nd dose on the recommended schedule is still probably better.
The FDA expanded the Pfizer/BioNTech RNA COVID-19 vaccine to 12-15 year olds yesterday.
🔵Excellent protection (100% = 0 cases versus 18)
🔵Excellent safety (On to younger children already)
🔵Better antibodies than adults
Also bodes well for other COVID vaccines in kids!🧵
FDA CBER head Dr. Marks:"It was a relatively straightforward decision. The response..was excellent and in fact it was even better, really, in the younger age group than it was in the 16-25 age group. The safety profile was very similar in 12-15-year-olds as in 16-25-year-olds."